• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
EW

EW

Edwards Lifesciences Corporation

NYSEHealthcareMedical - DevicesUS

USD86.00

-1.66 (-1.89%)

Rating:B+

Company Profile

CEO

Bernard J. Zovighian

IPO Date

2000-03-27

Sector

Healthcare

Industry

Medical - Devices

Exchange

NYSE

Country

US

Market Metrics

Open

$87.63

Prev. Close

$87.66

Day Low

$85.81

Day High

$87.90

52W Low

$72.30

52W High

$89.14

Market Cap

$49.52B

Volume

4.14M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentNeutral

Articles

10

Avg Positive

31.0%

Avg Negative

22.9%

Avg Neutral

46.2%

News Feed

Edwards Lifesciences Corp (EW) Stock Up 3.1% and Still Undervalued -- GF Score: 95/100

gurufocus.com·5/22/2026·↑ positive

Is EW Overvalued? DCF Says Worth $51

gurufocus.com·5/13/2026·↓ negative

Edwards Lifesciences Corporation (EW) Presents at Bank of America Global Healthcare Conference 2026 Transcript

seekingalpha.com·5/12/2026·↑ positive

Is Edwards Lifesciences Corp (EW) a Bargain After 3.5% Drop? GF Value Says Undervalued

gurufocus.com·5/11/2026·↓ negative

Edwards Lifesciences Announces Appointment of CFO

businesswire.com·5/4/2026·↑ positive

Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences' Resilia Tissue

businesswire.com·5/2/2026·↑ positive

Is EW Overvalued? DCF Says Worth $53

gurufocus.com·4/29/2026·↓ negative

Edwards Lifesciences to Present at the BofA Securities 2026 Health Care Conference

businesswire.com·4/28/2026·↓ negative

Head-To-Head Review: LENSAR (NASDAQ:LNSR) vs. Edwards Lifesciences (NYSE:EW)

defenseworld.net·4/27/2026·↑ positive

Riverwater Small Cap Strategy: Q1 2026 Buys, Sells, And Standouts

seekingalpha.com·4/26/2026·↑ positive